홈 > 시장보고서 > 의료기기 > 바이오매트리얼

시장보고서

상품코드

1881362

세계의 바이오필름 처리 시장 규모 조사 및 예측 : 제품별, 창상 유형별, 최종사용자별, 지역별 예측(2025-2035년)

Global Biofilms Treatment Market Size Study & Forecast, by Products by Wound Type by End User and Regional Forecasts 2025-2035

발행일: 2025년 12월 | 리서치사:

Bizwit Research & Consulting LLP | 페이지 정보: 영문 285 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오필름 처리 시장은 2024년에 약 21억 7,000만 달러로 평가되었고, 2025-2035년의 예측 기간에 CAGR 7.90%로 성장할 전망입니다.

바이오필름 처리는 상처 치유를 방해하고 만성 감염을 유발하는 복잡한 미생물 바이오필름을 관리하기 위해 고안된 전문적 개입법입니다. 이러한 치료법은 데브리드만 기기, 거즈, 드레싱, 겔, 연고 등 다양한 제품군에 걸쳐 있으며, 각각 바이오필름 구조 파괴, 미생물 증식 방지, 조직 재생 촉진을 목적으로 설계되어 있습니다. 시장 확대의 배경에는 만성 상처 증가, 당뇨병 및 외과적 개입의 발생률 증가, 첨단 상처 치료 요법에 대한 인식 증가 등이 있습니다.

효율적인 상처 관리 솔루션에 대한 수요가 증가함에 따라 의료시설 전반에 걸쳐 바이오필름을 표적으로 하는 치료법의 채택이 가속화되고 있습니다. 만성 상처, 특히 당뇨병성 족부궤양과 정맥성 하지궤양은 기존의 치료에 저항력이 강한 미생물 바이오필름을 가지고 있는 경우가 많기 때문에 전문 제품의 필요성을 강조합니다. 동시에, 창상청결법, 항균 드레싱, 바이오필름 파괴 젤의 기술 발전은 제조업체에게 수익성 높은 기회를 제공합니다. 그러나 높은 제품 비용과 엄격한 규제 승인 등의 요인으로 인해 2025년부터 2035년까지의 예측 기간 동안 시장 성장은 어느 정도 억제될 수 있습니다.

본 보고서에 포함된 세부 부문 및 하위 부문은 다음과 같습니다.

Porter's Five Forces 모델
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 기업간 경쟁 관계
Porter's Five Forces 예측 모델(2024년-2035년)
PESTEL 분석
- 정치
- 경제
- 사회
- 기술
- 환경
- 법률
주요 투자 기회
주요 성공 전략(2025년)
시장 점유율 분석(2024년-2025년)
세계의 가격 분석과 동향(2025년)
애널리스트의 제안과 결론

제5장 세계의 바이오필름 처리 시장 규모와 예측 : 제품별, 2025년-2035년

시장 개요
세계의 바이오필름 처리 시장 실적-잠재력 분석(2025년)
데브리드만용 기기
가제
드레싱
겔
연고

제6장 세계의 바이오필름 처리 시장 규모와 예측 : 창상 유형별, 2025년-2035년

시장 개요
세계의 바이오필름 처리 시장 실적-잠재력 분석(2025년)
외상성
외과성
개방성
당뇨병성 족부궤양
정맥성 종아리 궤양
화상

제7장 세계의 바이오필름 처리 시장 규모와 예측 : 최종사용자별, 2025년-2035년

시장 개요
세계의 바이오필름 처리 시장 실적과 잠재력 분석(2025년)
병원
외래수술센터(ASC)
창상관리 센터
홈케어

제8장 세계의 바이오필름 처리 시장 규모와 예측 : 지역별, 2025년-2035년

성장 지역별 시장 상황 개요
주요 국가 및 신흥 국가
북미
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 브라질
- 멕시코
중동 및 아프리카
- 아랍에미리트
- 사우디아라비아(KSA)
- 남아프리카공화국

제9장 경쟁 정보

주요 시장 전략
Smith & Nephew
- 기업 개요
- 주요 임원
- 기업 개요
- 재무 실적(데이터 입수 상황에 의한다)
- 제품 및 서비스 포트폴리오
- 최근 동향
- 시장 전략
- SWOT 분석
3M Healthcare
Molnlycke Health Care
ConvaTec Group Plc
Coloplast Group
Medline Industries Inc.
Cardinal Health
Derma Sciences Inc.
Hollister Incorporated
BSN medical GmbH
Paul Hartmann AG
Urgo Medical
Acelity L.P. Inc.
Integra LifeSciences Holdings Corporation
Molnlycke Health Care AB

LSH 25.12.22

The Global Biofilms Treatment Market is valued at approximately USD 2.17 billion in 2024 and is projected to grow at a CAGR of 7.90% during the forecast period 2025-2035. Biofilms treatments are specialized interventions designed to manage complex microbial biofilms that impede wound healing and contribute to chronic infections. These treatments span a range of products including debridement equipment, gauze, dressings, gels, and ointments, each engineered to disrupt biofilm structure, prevent microbial proliferation, and enhance tissue regeneration. The market expansion is propelled by the increasing prevalence of chronic wounds, rising incidence of diabetes and surgical interventions, and growing awareness regarding advanced wound care therapies.

The heightened demand for efficient wound management solutions has accelerated the adoption of biofilm-targeted therapies across healthcare facilities. Chronic wounds, particularly diabetic foot ulcers and venous leg ulcers, often harbor resilient microbial biofilms that resist conventional treatment, underscoring the necessity for specialized products. Concurrently, technological advancements in debridement methods, antimicrobial dressings, and biofilm-disrupting gels provide lucrative opportunities for manufacturers. Nevertheless, factors such as high product costs and stringent regulatory approvals may constrain market growth to some extent during the forecast horizon of 2025-2035.

The detailed segments and sub-segments included in the report are:

By Products:

Debridement Equipment
Gauze
Dressing
Gel
Ointment

By Wound Type:

Traumatic
Surgical
Open
Diabetic Foot
Venous Leg Ulcer
Burns

By End User:

Hospital
Ambulatory Surgical Centers (ASCs)
Wound Care Centers
Homecare

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Debridement equipment is anticipated to dominate the biofilms treatment market, as it plays a crucial role in physically removing biofilm-laden tissue, reducing microbial load, and preparing wounds for subsequent therapeutic applications. Hospitals and specialized wound care centers represent the primary end users due to their higher patient inflow, availability of advanced medical infrastructure, and expertise in managing chronic wounds.

Among product types, antimicrobial dressings and gels currently lead in revenue generation, owing to their broad adoption for managing diabetic foot ulcers and burns. These solutions provide sustained antimicrobial activity, promote tissue regeneration, and improve patient outcomes, thereby commanding higher market share and demonstrating consistent revenue traction.

North America led the market in 2025 due to a well-established healthcare infrastructure, increasing prevalence of chronic wounds, and higher adoption of advanced wound care technologies. Europe maintains a significant presence, driven by stringent healthcare standards and reimbursement policies. Asia Pacific is projected to be the fastest-growing region during the forecast period, supported by rising healthcare expenditure, expanding hospital networks, and increasing patient awareness regarding advanced wound care practices.

Major market players included in this report are:

Smith & Nephew
3M Healthcare
Molnlycke Health Care
ConvaTec Group Plc
Coloplast Group
Medline Industries Inc.
Cardinal Health
Derma Sciences Inc.
Hollister Incorporated
BSN medical GmbH
Paul Hartmann AG
Urgo Medical
Acelity L.P. Inc.
Integra LifeSciences Holdings Corporation
Molnlycke Health Care AB

Global Biofilms Treatment Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments and countries in recent years and forecast the values for the coming decade. The report integrates both qualitative and quantitative perspectives, offering a comprehensive understanding of market dynamics, including drivers, challenges, and emerging opportunities. Furthermore, it provides a detailed competitive landscape analysis, highlighting product innovations and strategic initiatives of key players to support informed investment and business decisions.

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level insights.
Competitive landscape with information on major players.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Biofilms Treatment Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Biofilms Treatment Market Forces Analysis

3.1. Market Forces Shaping The Global Biofilms Treatment Market (2024-2035)
3.2. Drivers
- 3.2.1. increasing prevalence of chronic wounds
- 3.2.2. rising incidence of diabetes and surgical interventions
3.3. Restraints
- 3.3.1. high product costs and stringent regulatory approvals
3.4. Opportunities
- 3.4.1. growing awareness regarding advanced wound care therapies

Chapter 4. Global Biofilms Treatment Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Biofilms Treatment Market Size & Forecasts by Products 2025-2035

5.1. Market Overview
5.2. Global Biofilms Treatment Market Performance - Potential Analysis (2025)
5.3. Debridement Equipment
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Gauze
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Dressing
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Gel
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
5.7. Ointment
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Biofilms Treatment Market Size & Forecasts by Wound Type 2025-2035

6.1. Market Overview
6.2. Global Biofilms Treatment Market Performance - Potential Analysis (2025)
6.3. Traumatic
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Surgical
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Open
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Diabetic Foot
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
6.7. Venous Lung Ulcer
- 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.7.2. Market size analysis, by region, 2025-2035
6.8. Burns
- 6.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.8.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Biofilms Treatment Market Size & Forecasts by End User 2025-2035

7.1. Market Overview
7.2. Global Biofilms Treatment Market Performance - Potential Analysis (2025)
7.3. Hospital
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.3.2. Market size analysis, by region, 2025-2035
7.4. Ambulatory Surgical Centers (ASCs)
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.4.2. Market size analysis, by region, 2025-2035
7.5. Wound Care Centers
- 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.5.2. Market size analysis, by region, 2025-2035
7.6. Homecare
- 7.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.6.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Biofilms Treatment Market Size & Forecasts by Region 2025-2035

8.1. Growth Biofilms Treatment Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America Biofilms Treatment Market
- 8.3.1. U.S. Biofilms Treatment Market
  - 8.3.1.1. Products breakdown size & forecasts, 2025-2035
  - 8.3.1.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.3.1.3. End User breakdown size & forecasts, 2025-2035
- 8.3.2. Canada Biofilms Treatment Market
  - 8.3.2.1. Products breakdown size & forecasts, 2025-2035
  - 8.3.2.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.3.2.3. End User breakdown size & forecasts, 2025-2035
8.4. Europe Biofilms Treatment Market
- 8.4.1. UK Biofilms Treatment Market
  - 8.4.1.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.1.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.1.3. End User breakdown size & forecasts, 2025-2035
- 8.4.2. Germany Biofilms Treatment Market
  - 8.4.2.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.2.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.2.3. End User breakdown size & forecasts, 2025-2035
- 8.4.3. France Biofilms Treatment Market
  - 8.4.3.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.3.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.3.3. End User breakdown size & forecasts, 2025-2035
- 8.4.4. Spain Biofilms Treatment Market
  - 8.4.4.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.4.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.4.3. End User breakdown size & forecasts, 2025-2035
- 8.4.5. Italy Biofilms Treatment Market
  - 8.4.5.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.5.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.5.3. End User breakdown size & forecasts, 2025-2035
- 8.4.6. Rest of Europe Biofilms Treatment Market
  - 8.4.6.1. Products breakdown size & forecasts, 2025-2035
  - 8.4.6.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.4.6.3. End User breakdown size & forecasts, 2025-2035
8.5. Asia Pacific Biofilms Treatment Market
- 8.5.1. China Biofilms Treatment Market
  - 8.5.1.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.1.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.1.3. End User breakdown size & forecasts, 2025-2035
- 8.5.2. India Biofilms Treatment Market
  - 8.5.2.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.2.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.2.3. End User breakdown size & forecasts, 2025-2035
- 8.5.3. Japan Biofilms Treatment Market
  - 8.5.3.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.3.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.3.3. End User breakdown size & forecasts, 2025-2035
- 8.5.4. Australia Biofilms Treatment Market
  - 8.5.4.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.4.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.4.3. End User breakdown size & forecasts, 2025-2035
- 8.5.5. South Korea Biofilms Treatment Market
  - 8.5.5.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.5.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.5.3. End User breakdown size & forecasts, 2025-2035
- 8.5.6. Rest of APAC Biofilms Treatment Market
  - 8.5.6.1. Products breakdown size & forecasts, 2025-2035
  - 8.5.6.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.5.6.3. End User breakdown size & forecasts, 2025-2035
8.6. Latin America Biofilms Treatment Market
- 8.6.1. Brazil Biofilms Treatment Market
  - 8.6.1.1. Products breakdown size & forecasts, 2025-2035
  - 8.6.1.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.6.1.3. End User breakdown size & forecasts, 2025-2035
- 8.6.2. Mexico Biofilms Treatment Market
  - 8.6.2.1. Products breakdown size & forecasts, 2025-2035
  - 8.6.2.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.6.2.3. End User breakdown size & forecasts, 2025-2035
8.7. Middle East and Africa Biofilms Treatment Market
- 8.7.1. UAE Biofilms Treatment Market
  - 8.7.1.1. Products breakdown size & forecasts, 2025-2035
  - 8.7.1.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.7.1.3. End User breakdown size & forecasts, 2025-2035
- 8.7.2. Saudi Arabia (KSA) Biofilms Treatment Market
  - 8.7.2.1. Products breakdown size & forecasts, 2025-2035
  - 8.7.2.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.7.2.3. End User breakdown size & forecasts, 2025-2035
- 8.7.3. South Africa Biofilms Treatment Market
  - 8.7.3.1. Products breakdown size & forecasts, 2025-2035
  - 8.7.3.2. Wound type breakdown size & forecasts, 2025-2035
  - 8.7.3.3. End User breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Smith & Nephew
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Financial Performance (Subject to Data Availability)
- 9.2.5. Product/Services Port
- 9.2.6. Recent Development
- 9.2.7. Market Strategies
- 9.2.8. SWOT Analysis
9.3. 3M Healthcare
9.4. Molnlycke Health Care
9.5. ConvaTec Group Plc
9.6. Coloplast Group
9.7. Medline Industries Inc.
9.8. Cardinal Health
9.9. Derma Sciences Inc.
9.10. Hollister Incorporated
9.11. BSN medical GmbH
9.12. Paul Hartmann AG
9.13. Urgo Medical
9.14. Acelity L.P. Inc.
9.15. Integra LifeSciences Holdings Corporation
9.16. Molnlycke Health Care AB

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,950

￦ 7,246,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 9,150,000

※ 부가세 별도